Go back

Karolinska signs drug deal with Canada

The Karolinska Institute in Stockholm will collaborate on drug development research with the Centre for Drug Research and Development (CDRD) in Canada.

The agreement, announced on 18 September, supports joint research projects, visits and training opportunities. The organisations are currently working to identify special areas of mutual interest.

This article on Research Professional News is only available to Research Professional or Pivot-RP users.

Research Professional users can log in and view the article via this link

Pivot-RP users can log in and view the article via this link.